TherapeuticsMD Inc (TXMD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TXMD.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 6 | $10 | $3 | $6 | $1.29 | 365.12% |
The Trend in the Analyst Price Target
Over the past 162 days, TXMD's average price target has gone down $0.57.
Over the past 13 months, TXMD's average upside potential has been 367.45%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-13 | 6 | 10 | 3.0 | 6.00 | 1.320 | 354.55% |
| 2021-06-05 | 6 | 10 | 3.0 | 6.00 | 1.210 | 395.87% |
| 2021-05-22 | 6 | 10 | 3.0 | 6.00 | 1.230 | 387.8% |
| 2021-05-15 | 6 | 10 | 3.0 | 6.00 | 1.050 | 471.43% |
| 2021-05-08 | 6 | 10 | 3.0 | 6.00 | 1.090 | 450.46% |
| 2021-04-25 | 6 | 10 | 3.0 | 6.17 | 1.170 | 427.35% |
| 2021-04-17 | 6 | 10 | 3.0 | 6.17 | 1.185 | 420.68% |
| 2021-04-10 | 6 | 10 | 3.0 | 6.17 | 1.320 | 367.42% |
| 2021-04-03 | 6 | 10 | 3.0 | 6.17 | 1.390 | 343.88% |
| 2021-03-20 | 6 | 10 | 3.0 | 6.17 | 1.540 | 300.65% |
| 2021-03-13 | 6 | 10 | 3.0 | 6.17 | 1.590 | 288.05% |
| 2021-03-06 | 6 | 10 | 3.0 | 6.17 | 1.370 | 350.36% |
| 2021-02-27 | 6 | 10 | 3.0 | 6.67 | 1.520 | 338.82% |
| 2021-02-20 | 6 | 10 | 3.0 | 6.67 | 1.770 | 276.84% |
| 2021-02-13 | 6 | 10 | 3.0 | 6.67 | 1.910 | 249.21% |
| 2021-02-06 | 6 | 10 | 3.0 | 6.67 | 1.900 | 251.05% |
| 2021-01-30 | 7 | 10 | 3.0 | 6.29 | 1.650 | 281.21% |
| 2021-01-23 | 7 | 10 | 3.0 | 6.43 | 1.500 | 328.67% |
| 2021-01-16 | 7 | 10 | 3.0 | 6.43 | 1.380 | 365.94% |
| 2021-01-09 | 7 | 10 | 3.0 | 6.57 | 1.330 | 393.98% |
| 2021-01-02 | 7 | 10 | 3.0 | 6.57 | 1.210 | 442.98% |
| 2020-12-26 | 8 | 10 | 1.2 | 5.90 | 1.190 | 395.8% |
| 2020-12-19 | 8 | 10 | 1.2 | 5.90 | 1.220 | 383.61% |
| 2020-12-09 | 8 | 13 | 1.2 | 6.90 | 1.160 | 494.83% |
| 2020-12-07 | 8 | 13 | 1.2 | 6.90 | 1.260 | 447.62% |
| 2020-11-28 | 8 | 13 | 1.2 | 6.90 | 1.370 | 403.65% |
| 2020-11-09 | 8 | 13 | 1.2 | 6.90 | 1.520 | 353.95% |
| 2020-10-23 | 7 | 13 | 1.2 | 6.46 | 1.480 | 336.49% |
| 2020-08-29 | 8 | 13 | 1.2 | 6.90 | 1.490 | 363.09% |
| 2020-08-06 | 8 | 13 | 1.2 | 6.90 | 1.610 | 328.57% |
| 2020-07-22 | 8 | 13 | 1.2 | 7.15 | 1.990 | 259.3% |
| 2020-07-14 | 8 | 13 | 1.2 | 7.15 | 1.490 | 379.87% |
| 2020-07-05 | 7 | 13 | 1.2 | 6.74 | 1.390 | 384.89% |
| 2020-06-17 | 8 | 13 | 1.2 | 7.15 | 1.245 | 474.3% |
| 2020-06-13 | 8 | 13 | 1.2 | 7.28 | NA | NA% |
| 2020-05-08 | 8 | 13 | 1.2 | 7.28 | NA | NA% |
TXMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 48 weeks, TXMD's average broker recommendation rating worsened by 0.17.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TXMD as an investment opportunity.
- TXMD has a lower variance in analysts' estimates than 2.89% of all US stocks.
- TXMD has a higher upside potential (average analyst target price relative to current price) than 97.06% of all US stocks.
- TXMD has a greater average analyst price target than 10.9% of all US stocks.
- TXMD has a greater number of analysts covering the stock than 79.4% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TherapeuticsMD Inc are LOGC, CLRB and ARAV.
Is TXMD a Buy, Hold or Sell? See the POWR Ratings now!